During the past decade, Yale New Haven Health System conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale New Haven Health System" #1 collaborator was "Food and Drug Administration (FDA)" with 2 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator, "Brown University" with 1 trials as a collaborator, "Case Western Reserve University" with 1 trials as a collaborator and "Columbia University" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Yale New Haven Health System" are "Heart Failure" (2 trials), "Peripheral Arterial Disease" (2 trials), "Acute Kidney Injury" (1 trials), "Anesthesia; Adverse Effect" (1 trials) and "Bedwetting" (1 trials). Many other conditions were trialed in "Yale New Haven Health System" in a lesser frequency.

Most popular intervention types in "Yale New Haven Health System" are "Drug" (8 trials), "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AbobotulinumtoxinA Treatment" (1 trials), "Belatacept" (1 trials), "Cyclosporine" (1 trials) and "Ertugliflozin 15 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale New Haven Health System" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Yale New Haven Health System". 1 are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Yale New Haven Health System, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Yale New Haven Health System, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Yale New Haven Health System has several departments that took part in Clinical trials: "Smilow Cancer Hospital Care Center at Greenwich" - 25 trials, "Smilow Cancer Hospital Care Center at Glastonbury" - 14 trials, "Smilow Cancer Hospital Care Center at Long Ridge" - 4 trials, "Oncology Associates of Bridgeport" - 2 trials